Patents
US 11458109 B2: Treatment of 22Q11.2 deletion syndrome with cannabidiol
- Granted
- 2022-10-04
- Filed
- 2019-12-12 application 16712066
- Type
- Utility · 15 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present technology relates to methods of treating one or more behavioral symptoms (for example, anxiety) of 22q11.2 deletion syndrome in a subject by administering, e.g., transdermally, an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of 22q11.2 deletion syndrome are treated in the subject.
Source: PVGPATDIS, file of 2026-04-10 (ipg221004.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. 13 patents | US company or organization | Devon, PA | ZYNERBA PHARMACEUTICALS, INC. Federal lobbying client EXACT high confidence: identical full name and state ZYNERBA PHARMACEUTICALS, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Terri Sebree | Gladwyne, PA | 27 | PVGPATDIS, file of 2026-04-10 | |
| Donna Gutterman | Raleigh, NC | 14 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/035 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P25/22 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2026-05-18 | Correction Supplemental confirmatory grant of security interest in united states patents | HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.) signed 2026-05-04 | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT CHICAGO, IL | 75642/639 | PASDL, file of 2026-10-15 |
| 2019-12-13 | Assignment Assignment of assignor's interest | SEBREE, TERRI signed 2019-12-11 GUTTERMAN, DONNA signed 2019-12-10 | ZYNERBA PHARMACEUTICALS, INC. DEVON, PA | 51288/158 | PASDL, file of 2026-10-15 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.